title: Three concerns with regards to the utilization of COX-2 inhibitor (celecoxib) in combination with standard chemoradiotherapy for nasopharyngeal carcinoma.
authors.forename: Swaroop
authors.initials: S
authors.lastname: Revannasiddaiah
authors.forename: Manoj
authors.initials: M
authors.lastname: Gupta
authors.forename: Rajeev
authors.initials: R
authors.lastname: Seam
authors.forename: Madhup
authors.initials: M
authors.lastname: Rastogi
mesh_terms: D059248:Chemoradiotherapy; D002945:Cisplatin / Q000008:administration & dosage*; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D009303:Nasopharyngeal Neoplasms / Q000628:therapy*; D011720:Pyrazoles / Q000008:administration & dosage*; D013449:Sulfonamides / Q000008:administration & dosage*
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D002945:Cisplatin